Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.48 USD
+0.04 (2.78%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $1.61 +0.13 (8.78%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Adicet Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -142.66 | -69.79 | -62.00 | -36.68 | -82.74 |
Depreciation/Amortization & Depletion | 25.59 | 2.67 | 1.72 | 1.37 | 0.13 |
Net Change from Assets/Liabilities | 0.25 | 2.74 | -6.06 | -13.28 | 6.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 23.10 | 19.61 | 15.28 | 7.04 | 2.73 |
Net Cash From Operating Activities | -93.72 | -44.77 | -51.05 | -41.55 | -73.68 |
Property & Equipment | -4.46 | -16.78 | -13.05 | -0.99 | -0.27 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 64.11 | 0.00 |
Investments | 0.00 | 0.00 | 10.25 | 52.09 | 44.40 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.46 | -16.78 | -2.80 | 115.22 | 44.13 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.39 | 45.11 | 242.95 | 0.46 | 56.47 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.15 | -3.60 | -0.26 | -0.16 | -0.02 |
Net Cash from Financing Activities | 0.24 | 41.51 | 242.69 | 0.30 | 56.45 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -97.95 | -20.04 | 188.84 | 73.97 | 26.89 |
Cash at Beginning of Period | 257.66 | 277.69 | 88.86 | 14.89 | 7.13 |
Cash at End of Period | 159.71 | 257.66 | 277.69 | 88.86 | 34.02 |
Diluted Net EPS | -3.31 | -1.70 | -2.00 | -5.01 | -16.86 |
Fiscal Year End for Adicet Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -57.92 | -28.02 | -142.66 | -113.17 | -63.28 |
Depreciation/Amortization & Depletion | 3.29 | 1.69 | 25.59 | 23.90 | 2.79 |
Net Change from Assets/Liabilities | -4.90 | -2.98 | 0.25 | 1.61 | 0.38 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.25 | 6.46 | 23.10 | 17.43 | 11.12 |
Net Cash From Operating Activities | -46.27 | -22.85 | -93.72 | -70.23 | -48.99 |
Property & Equipment | -0.54 | -0.24 | -4.46 | -4.33 | -3.42 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.54 | -0.24 | -4.46 | -4.33 | -3.42 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 111.31 | 111.11 | 0.39 | 0.23 | 0.23 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.14 | -0.14 | -0.15 | -0.07 | -0.01 |
Net Cash from Financing Activities | 111.17 | 110.97 | 0.24 | 0.16 | 0.22 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 64.36 | 87.88 | -97.95 | -74.40 | -52.20 |
Cash at Beginning of Period | 159.71 | 159.71 | 257.66 | 257.66 | 257.66 |
Cash at End of Period | 224.07 | 247.59 | 159.71 | 183.26 | 205.46 |
Diluted Net EPS | -0.33 | -0.35 | -0.68 | -1.16 | -0.75 |